• Veolity is the efficient way
    of reading chest CT studies.


  • Combine lung CAD,
    prior studies,
    and efficient reporting.

  • And your case is read

    in a heartbeat.


Lung cancer screening: Veolity™ is the reading platform for high-throughput lung CT environments. Built upon years of clinical and technical experience from large screening trials, it provides important innovations to improve the reading workflow and diagnostic quality.

Lung Cancer Screening in the USA

Lung cancer is the leading cause of cancer death in the U.S. Early detection is crucial in the fight against cancer. Accordingly, national recommendations for lung cancer screening among high-risk groups have recently been updated. What support do radiologists need to perform screening efficiently under these new conditions?

Advantages of Lung Cancer Screening with Veolity

News & Events

The World Conference on Lung Cancer 2022 (WCLC) takes places from August 6-9, 2022 in Vienna, Austria. At this world's largest international meeting of experts in the field of lung cancer and thoracic oncology MeVis presents its clinical solutions focusing on lung cancer diagnostics.


MeVis Medical Solutions AG presents radiological software solutions at the annual European Congress of Radiology (ECR) from July 13-17, 2022 in Vienna, Austria. Matching this year's motto "Building Bridges", the company's AI-enabled software solutions are a perfect fit and demonstrate how new ideas…


MeVis Medical Solutions AG exhibits together with its distributor SynApps Solutions at the NHS Long Term Plan 2021 meeting on November 30, 2021 in London, United Kingdom.


Contact Us

Comments about Veolity or this website? Choose from a variety of feedback options to contact us. Read more...